Addictive drugs and their relationship with infectious diseases

FEMS Immunology and Medical Microbiology

Volumn 47, Issue 3, 2006, Pages 330-342

  Friedman, Herman ^a   Pross, Susan ^a   Klein, Thomas W ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Cocaine; Drugs of abuse; Infectious disease; Marijuana; Nicotine; Opioids

Indexed keywords

ALCOHOL; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABIS; CIGARETTE SMOKE; COCAINE; DIAMORPHINE; DRONABINOL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; MORPHINE; NICOTINE; OPIATE; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALCOHOLISM; ANTIMICROBIAL ACTIVITY; APOPTOSIS; B LYMPHOCYTE; CANDIDA ALBICANS; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; CHRONIC LIVER DISEASE; CIGARETTE SMOKING; CYTOKINE PRODUCTION; CYTOTOXICITY; DENDRITIC CELL; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG ABUSE; ESCHERICHIA COLI; HAEMOPHILUS; HELPER CELL; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNE FUNCTION TEST; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; INFECTION; INFECTION RESISTANCE; LEGIONELLA PNEUMOPHILA; LUNG INFECTION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MOUSE STRAIN; MYCOBACTERIUM; NERVOUS SYSTEM; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; SHORT SURVEY; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION; TH2 CELL; TOXOPLASMA GONDII; TREPONEMA PALLIDUM;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; BACTERIAL INFECTIONS; DISEASE SUSCEPTIBILITY; HUMANS; IMMUNOLOGIC FACTORS; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; VIRUS DISEASES;

EID: 33745825224     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2006.00097.x     Document Type: Short Survey

References (120)

1. Adams HG & Jordan C (1984) Infections in the alcoholic. Med Clin North Am 68: 179-200.
2. Adler MW, Geller EB, Rogers TJ, Henderson EE & Eisenstein TK (1993) Opioids, receptors and immunity. Adv Exp Med Biol 335: 13-20.
3. Alak JI, Shahbazian M, Huang DS, Wang Y, Darban H, Jenkins EM & Watson RR (1993) Alcohol and murine acquired immunodeficiency syndrome suppression of resistance to Cryptosporidium parvum infection during modulation of cytokine production. Alcohol Clin Exp Res 17: 539-544.
4. Alicea C, Belkowski S, Eisenstein TK, Adler MW & Rogers TJ (1996) Inhibition of primary murine macrophage cytokine production in vitro following treatment with the kappa-opioid agonist U50, 488H. J Neuroimmunol 64: 83-90.
5. Allolio B, Schulte HM, Deuss U, Kallabis D, Hamel E & Winkelman W (1987) Effect of oral morphine and naltrexone on pituitary-adrenal response in man induced by human corticotrophin-releasing hormone. Acta Endocrinol (Copenhagen) 114: 509-514.
6. Almirall J, Bolibar I, Balanzo X & Gonzal CA (1999) Risk factors for community-acquired pneumonia in adults: a population-based case-control study. Eur Respir J 13: 349-355.
7. Anthony JC, Vlahov D, Nelson KE, Cohn S, Astemborski J & Solomon L (1991) New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1. Am J Epidemiol 134: 1175-1189.
8. Ashfaq MK, Watson ES & Elsohly HN (1987) The effect of subacute marijuana smoke inhalation on experimentally induced dermonecrosis by S. aureus infection. Immunopharmacol Immunotoxicol 9: 319-331.
9. Baczynsky WOT & Zimmerman AM (1983) Effects of Delta-9- tetrahydrocannabinol, cannabinoid and cannabidiol on the immune system in mice. II. In vitro investigation using cultured mouse splenocytes. Pharmacologist 26: 12-19.
10. Bagasra O & Forman L (1989) Functional analysis of lymphocytes subpopulations in experimental cocaine abuse. I. Dose-dependent activation of lymphocyte subsets. Clin Exp Immunol 77: 289-293.
11. Bagasra O & Pomerantz RJ (1993) Human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells in the presence of cocaine. J Infect Dis 168: 1157-1164.
12. Baldwin GC, Roth MD & Tshkin DP (1998) Acute and chronic effects of cocaine on the immune system and the possible link to AIDS. J Neuroimmunol 83: 133-138.
13. Bangsberg DR, Rosen I, Aragon T, Campbell A, Weir L & Perdreeau-Remington F (2002) Clostridial myonecrois cluster among injection drug users: a molecular epidemiology investigation. Arch Intern Med 162: 517-522.
14. Battjes RJ, Leukefeld CG, Pickens RW & Haverkos HW (1988) The acquired immunodeficiency syndrome and intravenous drug abuse. Bull Narc 40: 21-34.
15. Bautista AP (2001) Acute alcohol intoxication and endotoxemia desensitize HIV-1 gp 120-induced CC-chemokine production by Kupffer cells. Life Sci 68: 1939-1949.
16. Bayer BM, Daussin S, Hernandez M & Irvin L (1990) Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism. Neuropharmacol 29: 369-374.
17. Bayer BM, Gastonguay MR & Hernandez MD (1992) Distinction between the in vitro and in vivo inhibitory effects of morphine on lymphocyte proliferation based on agonist sensitivity and naltrexone reversibility. Immunopharmacology 23: 117-124.
18. Bermudez LE, Petrofsky M, Kolonoski P & Young LS (1992) An animal model of Mycobacterium avium complex disseminated infection after colonization of the intestinal tract. J Infect Dis 165: 75-79.
19. Bermudez KE, Wu M, Martinelli J & Young LS (1991) Ethanol affects release of TNF and GM-CSF and membrane expression of TNF receptors by human macrophages. Lymphokine Cytokine Res 10: 413-419.
20. Bermudez LE & Young LS (1991) Ethanol augments intracellular survival of Mycobacterium avium complex and impairs macrophage responses to cytokines. J Infect Dis 163: 1286-1292.
21. Bhargava HN, Thomas PT, Thorat S & House RV (1994) Effects of morphine tolerance and abstinence on cellular immune function. Brain Res 642: 1-10.
22. Bryant HU, Bernton EW & Holaday JW (1987) Immunosuppressive effects of chronic morphine treatment in mice. Life Sci 41: 1731-1738.
23. Bryant HU & Roudebush RE (1990) Suppressive effects of morphine pellet implants on in vivo parameters of immune function. J Pharmacol Exp Ther 255: 410-414.
24. Bussiere JJ, Adler MW, Rogers TJ & Eisenstein TK (1992) Differential effects of morphine and naltrexone on the antibody response in various mouse strains. Immunopharmacol Immunotoxicol 14: 657-673.
25. Cabral GA, Mc Nerney PJ & Mishkin EM (1986) Delta-9- tetrahydrocannabinol enhances release of herpes simplex virus type 2. J Gen Virol 67: 2017-2022.
26. Cabral GA, Mishkin EM, Marciano-Cabral F, Coleman P, Harris L & Munson AE (1986) Effect of delta-9-tetrahydrocannabinol on herpes simplex virus type 2 vaginal infection in the guinea pig. Proc Soc Exp Biol Med 182: 181-186.
27. Chahbazian LM, Darban HR, Darban JR, Stazzone AM & Watson RR (1992) Influence of the level of dietary ethanol in mice with murine AIDS on resistance to Streptococcus pneumoniae. Alcohol 27: 345-352.
28. Chaisson RW, Bacchetti P, Osmond D, Brodie B, Sande MA & Moss AR (1989) Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA 261: 561-565.
29. Chao CC, Molitor TW, Close K, Hus S & Peterson PK (1993) Morphine inhibits the release of tumor necrosis factor in human peripheral blood mononuclear cell cultures. Int J Immunopharmacol 15: 447-453.
30. Chao CC, Sharp BM, Pomeroy C, Filice GA & Peterson PK (1990) Lethality of morphine in mice infected with Toxoplasma gondii. J Pharmacol Exp Ther 252: 605-609.
31. Chiasson MW, Stoneburner RL, Hildebrandt DS, Ewing WE, Tetzak EE & Jaffe HW (1991) Heterosexual transmission of HIV-1 associated with the use of smokable freebase cocaine (crack). AIDS 5: 1121-1126.
32. Cook RT (1998) Alcohol abuse, alcoholism and damage to the immune system - a review. Alcohol Clin Exp Res 22: 1927-1942.
33. Cook RL, Pollock NK, Rao AK & Clark DB (2002) Increased prevalence of herpes simplex virus type 2 among adolescent women with alcohol use disorders. J Adolesc Health 30: 169-174.
34. Dingle GA & Oei TP (1997) Is alcohol a co-factor of HIV and AIDS? Evidence from immunological and behavioral studies. Psychol Bull 122: 56-71.
35. Djeu JY, Wang M & Friedman H (1991) Adverse effect of delta-9-tetrahydrocannabinol on human neutrophil function. Adv Exp Med Biol 288: 57-62.
36. Donahoe RM & Falek A (1988) Neuroimmunomodulation by opiates and other drugs of abuse: relationship to HIV infection and AIDS. Adv Biochem Psychopharmacol 44: 145-158.
37. Eisenstein TK, Hilburger ME & Lawrence DMP (1996) Immunomodulation by morphine and other opioids. In: Drugs of Abuse, Immunity and Infections (Friedman H, Klein TW & Specter S, eds) pp. 103-120. CRC Press, Inc, Boca Raton, FL.
38. Feng P, Wilson QM, Meissler JJ Jr, Adler MW & Eisenstein TK (2005) Increased sensitivity to Salmonella enterica serovar typhimurium infection in mice undergoing withdrawal from morphine is associated with suppression of interleukin-12. Infect Immun 73: 7953-7959.
39. Friedman H (1996) Drugs of abuse as possible co-factors in AIDS progression. Adv Exp Med Biol 402: 225-228.
40. Friedman H, Eisenstein TK, Madden J & Sharp BM (1996) AIDS, drugs of abuse and the neuroimmune axis. Plenum Press, New York, NY.
41. Friedman H, Klein TW & Bendinelli M (2005) Infectious Diseases and Substance Abuse. Springer Publishers, New York, NY.
42. Friedman H, Klein TW & Madden JJ (2001) Neuroimmune Circuits, Drugs of Abuse and Infectious Disease. Kluwer Academic/Plenum Publishers, New York, NY.
43. Friedman H, Newton C & Klein TW (2003) Microbial infection, immunomodulation and drugs of abuse. Clin Microbiol Rev 16: 209-218.
44. Friedman H, Shivers S & Klein TW (1994) Drugs of abuse and immune system. In: Immunotoxicology and Immunopharmacology (Dean JH, Luster MI, Munson AE & Kimber I, eds), pp. 103-109. Raven Press, New York, NY.
45. Gao B (2002) Interaction of alcohol and hepatitis viral proteins, implication in synergistic effect of alcohol drinking and viral hepatitis on liver injury. Alcohol 27: 69-72.
46. Grimm MC, Ben-Baruch A, Taub DD, Howard OM, Resau JH, Wang JM, Ali H, Richardson R, Snyderman R & Oppenheim JJ (1998) Opiates transdeactivate chemokine receptors: delta and mu opiate receptor-mediated heterologous desensitization. J Exp Med 188: 317-325.
47. Hakki A, Hallquist N, Friedman H & Pross S (2000) Differential impact of nicotine on cellular proliferation and cytokine production by LPS-stimulated murine splenocytes. Int J Immunopharmacol 22: 403-410.
48. Hallquist N, Hakki A, Wecker L, Friedman H & Pross S (2000) Differential effects of nicotine and aging on splenocyte proliferation and the production of Th1 vs. Th2-type cytokines. Proc Soc Exp Biol Med 224: 1451-1465.
49. Houghtling RA, Mellon RD, Tan RJ & Bayer BM (2000a) Acute effects of morphine on blood lymphocyte proliferation and plasma IL-6 levels.
50. Houghtling RA, Mellon RD, Tan RJ & Bayer BM (2000b) Acute effects of morphine on blood lymphocyte proliferation and plasma IL-6 levels. Ann NY Acad Sci 917: 771-777.
51. Jerrells TR (2002a) Association of alcohol consumption and exaggerated immunopathologic effects in the liver induced by infectious organism. Front Biosci 7: d1487-d1493.
52. Jerrells TR (2002b) Role of activated CD8+ T cells in the initiation and continuation of hepatic damage. Alcohol 27: 45-52.
53. Jerrells TR, Saad AJ & Domiati-Saad R (1992) Effects of ethanol on parameters of cellular immunity and host defense mechanisms to infectious agents. Alcohol 9: 459-463.
54. Kaminski N, Koh WS, Yang KH, Lee M & Kessler FK (1994) Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism. Biochem Pharm 48: 1899-1908.
55. Kawakami Y, Klein TW, Newton C, Mc Carthy CA, Djeu J, Dennert G, Specter S & Friedman H (1988) Suppression by cannabinoids of a cloned cell line with natural killer cell activity. Proc Soc Exp Biol Med 187: 355-359.
56. Klein TW & Friedman H (1990) Modulation of murine immune cell function by marijuana components. In: Drugs of Abuse and Immune Function (Watson R, ed) pp. 87-111. CRC Press, Inc, Boca Raton, FL.
57. Klein T, Friedman H & Specter S (1998) Marijuana, immunity and infection. J Neuroimmunol 83: 102-115.
58. Klein TW, Lane B, Newton CA & Friedman H (2000) The cannabinoid system and cytokine network. Proc Soc Exp Biol Med 225: 1-8.
59. Klein TW, Newton C & Friedman H (1987) Inhibition of natural killer cell function by marijuana components. J Toxicol Environ Health 20: 321-332.
60. Klein TW, Newton CA, Widen R & Friedman H (1985) The effect of delta-9-tetrahydrocannabinol and 11-hydroxy-delta-9-tetrahydrocannabinol on T lymphocyte and B lymphocyte mitogen responses. J Immunopharmacol 7: 451-466.
61. Klein TW, Newton C, Widen R & Friedman H (1993) Delta-9- tetrahydrocannabinol injection induces cytokine-mediated mortality of mice infected with Legionella pneumophila. J Pharmacol Exp Ther 267: 635-640.
62. Liu Y, Whitlock BB, Pultz JA & Wolfe SA Jr (1995) Sigma-1 receptors modulate functional activity of rat splenocytes. J Neuroimmunol 59: 143-154.
63. Lyman WD (1993) Perinatal AIDS: drugs of abuse and transplacental infection. Adv Exp Med Biol 335: 211-217.
64. Mac Farlane AS, Peng X, Meissler JJ Jr., Rogers TJ, Geller EB, Adler MW & Eisenstein TK (2000) Morphine increases susceptibility to oral Salmonella typhimurium infection. J Infect Dis 181: 1350-1358.
65. Mansell PW (1984) Acquired immune deficiency syndrome leading to opportunistic infections, Kaposi's sarcoma and other malignancies. Crit Rev Clin Lab Sci 20: 191-204.
66. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC & Bonner TI (1990) Structure of cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-564.
67. Matsumoto RR, Mc Cracken KA, Pouw B, Zhang Y & Bowen WD (2002) Involvement of sigma receptors in the behavioral effects of cocaine: evidence from novel ligands and antisense oligodeoxynucleotides. Neuropharmacol 42: 1043-1055.
68. Matsunaga K, Klein TW, Friedman H & Yamamoto Y (2001) Involvement of nicotinic acetylcholine receptors in suppression of antimicrobial activity and cytokine responses of alveolar macrophages to Legionella pneumophila infection by nicotine. J Immunol 167: 6518-6524.
69. Maurice T, Martin-Pardon R, Romieu P & Matsumoto RR (2002) Sigma (1) receptor antagonists represent a new strategy against cocaine addiction and toxicity. Neurosci Biobehav Rev 26: 499-527.
70. McCarthy L, Wetzel M, Sliker JK, Eisenstein TK & Rogers TJ (2001) Opioids, opioid receptors, and the immune response. Drug Alcohol Depend 62: 111-123.
71. Mechoulam R, Ben-Zvi Z, Yagnitinsky B & Shani A (1969) A new tetrahydrocannabinolic acid. Tetrahedron Let 28: 2339-2341.
72. Mellon RD & Bayer BM (1998) Evidence for central opioid receptors in the immunomodulatory effects of morphine: review of potential mechanism(s) of action. J Neuroimmunol 83: 19-28.
73. Meyerhoff DJ (2001) Effects of alcohol and HIV infection on the central nervous system. Alcohol Res Health 25: 288-298.
74. Mishkin EM & Cabral GA (1985) Delta-9-tetrahydrocannabinol decreases host resistance to herpes simplex virus type 2 vaginal infection in the B6C3F1 mouse. J Gen Virol 66: 2539-2549.
75. Molitor TW, Morilla A, Risdahl JM, Murtaugh MP, Chao CC & Peterson PK (1992) Chronic morphine administration impairs cell-mediated immune responses in swine. J Pharmacol Exp Ther 260: 581-586.
76. Morahan PS, Klykken PC, Smith SH, Harris LS & Munson AE (1979) Effects of cannabinoids on host resistance to Listeria monocytogenes and herpes simplex virus. Infect Immun 23: 670-674.
77. Munro S, Thomas KL & Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365: 61-65.
78. Nelson S & Kolls JK (2002) Alcohol, host defense and society. Nat Rev Immunol 2: 205-209.
79. Newton C, Klein TW & Friedman H (1994) Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by delta-9- tetrahydrocannabinol injection. Infect Immun 62: 4015-4020.
80. Newton C, Klein T & Friedman H (1998) The role of macrophages in THC-induced alteration of the cytokine network. Adv Exp Med Biol 437: 207-214.
81. Nieman RB, Fleming J, Coker RJ, Harris JR & Mitchell GH (1993) The effect of cigarette smoking on the development of AIDS in HIV-1 seropositive individuals. AIDS 7: 705-710.
82. Ouyang Y, Virsch N, Hao P, Aubrey MT, Mukerjee N, Bierer BE & Freed BM (2000) Suppression of human IL-1β, IL-2, IFN-γ and TNF-α production by cigarette smoke extracts. J Allergy Clin Immunol 106: 280-287.
83. Panaslak W, Gumulka S, Kobus M & Luczak M (1990) The influence of morphine on development of HSV-1 and M-MSV virus infection in mice. Acta Microbiol Pol 39: 215-218.
84. Paradise LJ & Friedman H (1993) Syphilis and drugs of abuse. Adv Exp Med Biol 335: 81-87.
85. Pellegrino TC, Dunn KL & Bayer BM (2001) Mechanisms of cocaine-induced decreases in immune cell function. Int Immunopharmacol 1: 665-675.
86. Peng X, Cebra JJ, Adler MW, Meissler JJ Jr, Cowan A, Feng P & Eisenstein TK (2001) Morphine inhibits mucosal antibody responses and TGF-β mRNA in gut-associated lymphoid tissue following oral cholera toxin in mice. J Immunol 167: 3677-3681.
87. Peterson PK, Gekker G, Chao CC, Schut R, Molitor TW & Balfour HH Jr (1991) Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell co-cultures. Involvement of transforming growth factor-beta. J Immunol 146: 81-84.
88. Peterson PK, Gekker G, Hu S, Sheng WS, Molitor TW & Chao CC (1995) Morphine stimulates phagocytosis of Mycobacterium tuberculosis by human microglial cells: involvement of a G protein-coupled opiate receptor. Adv Neuroimmunol 5: 299-309.
89. Rahim RT, Meissler JJ Jr, Cowan A, Rogers TJ, Geller EB, Gaughan J, Adler MW & Eisenstein TK (2001) Administration of mu-, kappa- or delta-2-receptor agonists via osmotic mini pumps suppresses murine splenic antibody responses. Int Immunopharmacol 1: 2001-2009.
90. Reichman LB, Felton CP & Edsall JR (1979) Drug dependence, a possible new risk factor for tuberculosis disease. Arch Intern Med 139: 337-339.
91. Reisine T & Bell GI (1993) Molecular biology of opioid receptors. Trends Neurosci 16: 506-510.
92. Risdahl JM, Khanna KV, Peterson PK & Molitor TW (1998) Opiates and infection. J Neuroimmunol 83: 4-18.
93. Risdahl JM, Peterson PK, Chao CC, Pijoan C & Molitor TW (1993) Effects of morphine dependence on the pathogenesis of swine herpesvirus infection. J Infect Dis 167: 1281-1287.
94. Risdahl JM, Peterson PK & Molitor TW (1996) Opiates, infection and immunity. In: Drugs of Abuse, Immunity and Infections (Friedman H, Klein TW & Specter S, eds)) CRC Press, Inc, Boca Raton, FL.
95. Roy S, Balasubramanian S, Sumandeep S, Charboneau R, Wang J, Melnyk D, Beilman GJ, Vatassery R & Barke RA (2001) Morphine directs T cells toward Th2 differentiation. Surgery 130: 304-309.
96. Roy S, Barke RA & Loh HH (1998) Mu-opioid receptor-knockout mice: role of mu-opioid receptor in morphine mediated immune functions. Brain Res Mol Brain Res 61: 190-194.
97. Roy S, Wang J, Charboneau R, Loh HH & Barke RA (2005) Morphine induces CD4+ T cell IL-4 expression through an adenylyl cyclase mechanism independent of the protein kinase A pathway. J Immunol 175: 6361-6367.
98. Ruiz M, Ewig S, Marcos MA, Martinez JA, Arancibia F, Mensa J & Torres A (1999) Etiology of community acquired pneumonia: impact of age, co-morbidity and severity. Am J Respir Crit Care Med 160: 397-405.
99. Scott JM (1969) The White Poppy. A History of Opium. Cox and Wyman Ltd, London.
100. Sibley D & Jerrells TR (2000) Alcohol consumption by C57BL/6 mice is associated with depletion of lymphoid cells from the gut-associated lymphoid tissues and altered resistance to oral infections with Salmonella typhimurium. J Infect Dis 182: 482-489.
101. Sibley DA, Osna N, Kusynski C, Wilkie L & Jerrells (2001) Alcohol consumption is associated with alterations in macrophage responses to interferonγ and infection by Salmonella typhimurium. FEMS Immunol Med Microbiol 32: 73-83.
102. Siegel L (1986) AIDS: relationship to alcohol and other drugs. J Subst Abuse Treat 3: 271-274.
103. Slavinsky J III, Myers T, Swoboda RK, Leigh JE, Hager S & Fidel PL Jr (2002) Th1/Th2 cytokine proliferation in saliva of HIV-positive smokers with oropharengeal candidiasis. Oral Microbiol Immunol 17: 38-43.
104. Sopori M (2002) Effects of cigarette smoke on the immune system. Nat Rev Immunol 2: 372-377.
105. Sopori ML & Kozak W (1998) Immunomodulatory effects of cigarette smoke. J Neuroimmunol 83: 148-156.
106. Sopori ML, Lozak W, Savage SM, Geng Y, Soszynski D, Kluger MJ, Perryman EK & Snow GE (1998) Effect of nicotine on the immune system: possible regulation of immune responses by central and peripheral mechanisms. Psychoneuroendocrinol 23: 189-204.
107. Specter S, Lancz G, Westrich G & Friedman H (1991) Delta-9-tetrahydrocannabinol augments murine retroviral induced immunosuppression and infection. Int J Immunopharmacol 13: 411-417.
108. Starec M, Rouveix B, Sinet M, Chau F, Desforges B, Pocidalo JJ & Lechat P (1991) Immune status and survival of opiate- and cocaine-treated mice infected with Friend virus. J Pharmacol Exp Ther 259: 745-750.
109. Stoltz DA, Nelson S, Kolls JK, Zhang P, Bohm RP Jr, Murphy-Corb M & Bagby GJ (2000) In vitro ethanol suppresses alveolar macrophage TNF-α during simian immunodeficiency virus infection. Am J Respir Crit Care Med 161: 135-140.
110. Su TP (1991) Sigma receptors. Putative links between nervous, endocrine and immune systems. Eur J Biochem 200: 633-642.
111. Szabo G, Mandrekar P, Dolganiuc A, Catalano D & Kodys K (2001) Reduced allo-reactive T-cell activation after alcohol intake is due to impaired monocyte accessory cell function and correlates with elevated IL-10, IL-13, and decreased IFNγ levels. Alcohol Clin Exp Res 25: 1766-1772.
112. Szabo I, Rojavin M, Bussiere JL, Eisenstein TK, Adler MW & Rogers TJ (1993) Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids. J Pharmacol Exp Ther 267: 703-706.
113. Tubaro E, Borelli G, Croce C, Cavallo G & Santiangeli C (1983) Effect of morphine on resistance to infection. J Infect Dis 148: 656-666.
114. Vlahov D, Anthony JC, Celentano D, Solomon L & Chowdhury N (1991) Trends of HIV-1 risk reduction among initiates into intravenous drug use 1982-1987. Am J Drug Alcohol Abuse 17: 39-48.
115. Wagner F, Rink R, Hart R, Lersch C, Dancygier H & Classen M (1992) Ethanol.
116. Wang J, Barke RA, Charboneau & Roy S (2005) Morphine impairs host innate immune response and increases susceptibility to streptococcus pneumoniae lung infection. J Immunol 174: 426-434.
117. Wang Y, Huang DS, Giger PT & Watson RR (1993) Ethanol-induced modulation of cytokine production by splenocytes during murine retrovirus infection causing murine AIDS. Alcohol Clin Exp Res 17: 1035-1039.
118. Wang JY, Liang B & Watson RR (1997) Alcohol consumption alters cytokine release during murine AIDS. Alcohol 14: 155-159.
119. Wang Y & Watson RR (1994) Chronic ethanol consumption before retrovirus infection is a cofactor in the development of immune dysfunction during murine AIDS. Alcohol Clin Exp Res 18: 976-981.
120. Yamamoto Y, Klein TW & Friedman H (1993) Differential effects of ethanol on permissive vs. nonpermissive macrophages infected with Legionella pneumophila. Proc Soc Exp Biol Med 203: 323-327.